Funding for this research was provided by:
Received: 10 May 2020
Accepted: 23 September 2020
First Online: 14 October 2020
Ethics approval and consent to participate
: Prior to performing this study we obtained an institutional review board waiver from Brigham and Women’s Hospital. We received permission to use the Marketscan® data. IBM is the owner of the data.This research was done without patient involvement. Patients were not invited to comment on the study design and were not consulted to develop patient relevant outcomes or interpret the results. Patients were not invited to contribute to the writing or editing of this document for readability or accuracy.
: Not applicable.
: QDT reports honoraria from Astellas, Bayer, Janssen, Insightec and Intuitive Surgical. ASK reports consulting fees from Janssen, Merck, Pfizer, Bristle-Meyers Squib, Insightec and Profound. RDU reports consulting fees from Medtronic and Merck. All other authors declare that they have no conflict of interest.